19,26,27-TRINOR-1alpha,25-DIHYDROXYVITAMIN D3 COMPOUNDS
First Claim
1. A method of treating a subject suffering from a biological disorder, comprising administering an effective amount of a compound or a composition comprising an effective amount of the compound and a pharmaceutical carrier to the subject, wherein the biological disorder is selected from renal osteodystrophy, secondary hyperparathyroidism, psoriasis, type I diabetes, lupus, rheumatoid arthritis, or a cancer selected from leukemia, colon cancer, breast cancer, or prostate cancer, and the compound has the formula 1, wherein, X1, X2, and X3 are independently selected from H or hydroxy protecting groups;
- and R1 and R2 are independently selected from H or straight or branched chain alkyl groups having from 1 to 8 carbon atoms;
or R1 and R2 join together to form a group of formula 2 where the wavy line indicates the point of attachment to the carbon at the 2 position of the vitamin D analog, and R3 and R4 are independently selected from H or straight or branched chain alkyl groups having from 1 to 8 carbon atoms.
0 Assignments
0 Petitions
Accused Products
Abstract
Compounds of formula 1 are provided where X1, X2, and X3 are independently selected from H or hydroxy protecting groups, and R1 and R2 have the definitions provided herein. Such compounds may be used in preparing pharmaceutical compositions and are useful in treating a variety of biological conditions.
-
Citations
15 Claims
-
1. A method of treating a subject suffering from a biological disorder, comprising administering an effective amount of a compound or a composition comprising an effective amount of the compound and a pharmaceutical carrier to the subject, wherein the biological disorder is selected from renal osteodystrophy, secondary hyperparathyroidism, psoriasis, type I diabetes, lupus, rheumatoid arthritis, or a cancer selected from leukemia, colon cancer, breast cancer, or prostate cancer, and the compound has the formula 1,
wherein, X1, X2, and X3 are independently selected from H or hydroxy protecting groups; - and
R1 and R2 are independently selected from H or straight or branched chain alkyl groups having from 1 to 8 carbon atoms;
or R1 and R2 join together to form a group of formula 2where the wavy line indicates the point of attachment to the carbon at the 2 position of the vitamin D analog, and R3 and R4 are independently selected from H or straight or branched chain alkyl groups having from 1 to 8 carbon atoms. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15)
- and
Specification